Aclaris Therapeutics Inc (ACRS) Technical Analysis
$4.19▲1.21%
Market is closed - opens 7 PM, 06 Apr 2026
Insights
- Aclaris Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Aclaris Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Aclaris Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Aclaris Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.28 | Sell |
Stochastic | 96.91, 70.14 | Neutral |
Ultimate Oscillator | 72.56 | Sell |
Stochastic Relative Strength Index | 62.83, 43.91 | Neutral |
Moving Average Convergence Divergence | 0.11, 0.08 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.63 | Buy |
20 | 3.57 | Buy |
50 | 3.52 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.68 | Buy |
20 | 3.58 | Buy |
50 | 3.43 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.58 | Buy |
20 | 3.49 | Buy |
50 | 3.54 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.79 | Buy |
20 | 3.72 | Buy |
50 | 3.65 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.85 | Buy |
20 | 3.77 | Buy |
50 | 3.67 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 4.08 |
Resistance L2 | 3.92 |
Resistance L1 | 3.84 |
Pivot Point | 3.68 |
Support L1 | 3.59 |
Support L2 | 3.43 |
Support L3 | 3.35 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.